Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Stock Information for Inspira Technologies Oxy B.H.N. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inspira Technologies Oxy B.H.N. Ltd.

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board
Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company's Board of Directors
Nano Dimension Continues Execution of Cost Savings Initiatives
Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign
Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination
Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company
Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?
Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.